Pupil control
Positioned to support pupillary constriction when surgeons want a controlled close.
INTRAOCULAR SOLUTION
OP‑CHOL Carbachol Ophthalmic Solution
Intraoperative miotic positioned to help surgeons achieve a controlled, stable pupil at the end of cataract surgery and other anterior segment procedures as per local protocols.
Role
Intraoperative miotic
Supports pupil constriction
Strength
0.01%
As per Agaaz OP‑CHOL line
Partner support
Strong documentation
For onboarding & registrations
Where OP‑CHOL fits
Surgeons may prefer a smaller pupil at the end of the case for controlled wound closure and postoperative stability. OP‑CHOL is positioned to support this step when a quick, intraoperative miotic effect is desired.
CLINICAL PURPOSE
A simple step that supports a controlled finish
OP‑CHOL is built around clarity and predictability. It’s positioned for ophthalmic procedures where surgeons want a controlled pupillary constriction at the end of surgery, aligned to their standard OT protocol.
OT-friendly
Designed to fit cleanly into existing protocols without adding friction to the workflow.
Consistency
Positioned for predictable handling so teams can standardise the end-of-case step.
Partner readiness
Strong documentation support available for product onboarding and registrations.
SPECIFICATIONS
Quick-scan specs in a circular format
A clean scan of the essentials. For full technical tables, artwork, and pack details, use the brochure download.
Brand
OP‑CHOL
Miotic
Generic
Carbachol
Ophthalmic solution
Strength
0.01%
as per line
Use
Intraoperative
end-of-case step
Want to add OP‑CHOL to your cataract range?
Share your market and expected quantities. We’ll respond with commercial details and the documentation pack aligned to your route.
INTRAOCULAR SOLUTION
OP‑CHOL Carbachol Ophthalmic Solution
Intraoperative miotic positioned to help surgeons achieve a controlled, stable pupil at the end of cataract surgery and other anterior segment procedures as per local protocols.
Role
Intraoperative miotic
Supports pupil constriction
Strength
0.01%
As per Agaaz OP‑CHOL line
Partner support
Strong documentation
For onboarding & registrations
Where OP‑CHOL fits
Surgeons may prefer a smaller pupil at the end of the case for controlled wound closure and postoperative stability. OP‑CHOL is positioned to support this step when a quick, intraoperative miotic effect is desired.
CLINICAL PURPOSE
A simple step that supports a controlled finish
OP‑CHOL is built around clarity and predictability. It’s positioned for ophthalmic procedures where surgeons want a controlled pupillary constriction at the end of surgery, aligned to their standard OT protocol.
Pupil control
Positioned to support pupillary constriction when surgeons want a controlled close.
OT-friendly
Designed to fit cleanly into existing protocols without adding friction to the workflow.
Consistency
Positioned for predictable handling so teams can standardise the end-of-case step.
Partner readiness
Strong documentation support available for product onboarding and registrations.
SPECIFICATIONS
Quick-scan specs in a circular format
A clean scan of the essentials. For full technical tables, artwork, and pack details, use the brochure download.
Brand
OP‑CHOL
Miotic
Generic
Carbachol
Ophthalmic solution
Strength
0.01%
as per line
Use
Intraoperative
end-of-case step
Want to add OP‑CHOL to your cataract range?
Share your market and expected quantities. We’ll respond with commercial details and the documentation pack aligned to your route.